Journals / Ankara Üniversitesi Tıp Fakültesi Mecmuası / 2020 / Cilt: 73 - Sayı: 1

Serum Procalcitonin as a Marker for Differential Diagnosis Between Bacterial Pneumonia and Scleroderma-related Lung Disease

Skleroderma İlişkili İnterstisyel Akciğer Hastalığı ve Bakteriyel Pnömoni’nin Ayırıcı Tanısında Prokalsitonin Düzeylerinin Değerlendirilmesi

Pages
14–19
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

PCT level was higher in pneumonia group than in SSK-ILD group (8.1±15 and 0.1±0.4, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Scleroderma/Systemic Sclerosis (SSc) is characterized by progressive fibrosis.
📊
Key Findings & Data:Of these, 27 patients with SSc-ILD whose PCT levels checked, and 18 patients diagnosed with bacterial pneumonia were included to the study.
💡
Conclusion & Impact:PCT level was higher in pneumonia group than in SSK-ILD group (8.1±15 and 0.1±0.4, p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Scleroderma/Systemic Sclerosis (SSc) is characterized by progressive fibrosis. SSc related interstitial lung disease (SSc-ILD) is a major cause of mortality and morbidity among SSc patients. Procalcitonin (PCT) is used for diagnosis and follow up bacterial infections and sepsis. Bacterial pneumonia is an important situation that should be considered in the differential diagnosis of lung diseases. In this study, we aimed to investigate the diagnostic value of serum PCT between in patients with SSc-ILD and bacterial pneumonia. Materials and Methods: One-hundred and fifty-one SSc patients were retrospectively evaluated. Of these, 27 patients with SSc-ILD whose PCT levels checked, and 18 patients diagnosed with bacterial pneumonia were included to the study. Results: Twenty-seven (23 female, four male) patients with a mean age of 49.3±13.5 and a mean duration of disease 9.9±5.9 years were evaluated in the SSK-ILD group. There were 17 (two female, 15 male) patients with a mean age of 75.2±14.6 in pneumonia group. PCT level was higher in pneumonia group than in SSK-ILD group (8.1±15 and 0.1±0.4, p

Özet

Amaç: Skleroderma/Sistemik skleroz (SSk), fibrozis ile karakterize olan otoimmün bir bağ doku hastalığıdır. SSk ilişkili interstisyel akciğer hastalığı(SSk-İAH) önemli mortalite ve morbidite nedenlerinden birisidir. Prokalsitonin (PCT) bakteriyel enfeksiyonlar ve sepsisin tanısında ve takibindekullanılan bir belirteçtir. Bakteriyel pnömoni akciğer hastalıklarının ayırıcı tanısında önemli bir yer tutmaktadır. Bu çalışmada SSk-İAH ve bakteriyelpnömoni hastalarının ayırıcı tanısında serum PCT düzeylerinin tanısal değerini araştırmak amaçlanmıştır.Gereç ve Yöntem: SSk tanısı ile kliniğimizde takipli olan 151 hasta retrospektif olarak değerlendirildi, bu hastalar içerisinden PCT bakılmış 27 SSkİAHhastası ve 18 bakteriyel pnömoni tanısı almış olan hasta çalışmaya dahil edildi.Bulgular: SSk-İAH grubunda yaş ortalaması 49,3±13,5, ortalama hastalık süresi 9,9±5,9 (aralık; 2,5-25) olan 27 (23 kadın, dört erkek) hastadeğerlendirildi. Pnömoni grubunda yaş ortalaması 75,2±14,6 olan 17 (iki kadın, 15 erkek) hasta bulunmaktaydı. Pnömoni grubunda PCT düzeyiSSk-İAH grubuna göre belirgin olarak yüksek saptandı (sırasıyla; 8,1±15 ve 0,1±0,4, p

🔖

Cite This Article

YAYLA, M. E., TORGUTALP, M., KINIKLI, S., OKATAN, İ. E., KINIKLI, G. (2022). Serum Procalcitonin as a Marker for Differential Diagnosis Between Bacterial Pneumonia and Scleroderma-related Lung Disease. Ankara Üniversitesi Tıp Fakültesi Mecmuası, Cilt: 73 - Sayı: 1, 14–19. https://ajindex.com/articles/440139

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Varga J. Systemic sclerosis: an update. Bull NYU Hosp Jt Dis. 2008;66:198- 202
  2. Şendur N, Şendur ÜG. Skleroderma. Türkiye Klinikleri. 2018;15-20
  3. Goh NS, Desai SR, Veeraraghavan S, et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med. 2008;177:1248-1254
  4. Mathai SC, Danoff SK. Management of interstitial lung disease associated with connective tissue disease. BMJ. 2016;352:h6819
  5. Türktaş H. İnterstisyel Akciğer Hastalıkları ve Patologlara Notlar. Turkiye Klinikleri J Med Pathol-Special Topics. 2018;3:183-188
  6. Demirdağ F. Fibrozisle Karakterize İnterstisyel Akciğer Hastalıklarında Ayırıcı Tanı. Turkiye Klinikleri J Med Pathol-Special Topics. 2018;3:167-176
  7. Mehanic S, Baljic R. The importance of serum procalcitonin in diagnosis and treatment of serious bacterial infections and sepsis. Mater Sociomed. 2013;25:277-281
  8. Uzzan B, Cohen R, Nicolas P, et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006;34:1996-2003
  9. Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13:426-435
  10. Bilgili B, Haliloğlu M, Aslan MS, et al. Diagnostic Accuracy of Procalcitonin for Differentiating Bacteraemic Gram-Negative Sepsis from Gram-Positive Sepsis. Turk J Anaesthesiol Reanim. 2018;46:38-43
  11. Duman S, Periprostetik Eklem Enfeksiyonu Tanısında C-Reaktif ve Procalcitonin Sensitivite ve Spesifiteleri. Kocaeli Tıp Dergisi. 2019;8:210- 214
  12. Karakaya Z, Akyol PY, Topal F, et al. Akut pankreatitte prokalsitonin düzeyinin mortalite üzerine etkisi, Cukurova Medical Journal. 2018;43:617-623
  13. Schuetz P, Wirz Y, Sager R, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level metaanalysis. Lancet Infect Dis. 2018;18:95-107
  14. Kisacik B, Kalyoncu U, Erol MF, et al. Accurate diagnosis of acute abdomen in FMF and acute appendicitis patients: how can we use procalcitonin? Clin Rheumatol. 2007;26:2059-2062
  15. Choi ST, Song JS. Serum Procalcitonin as a Useful Serologic Marker for Differential Diagnosis between Acute Gouty Attack and Bacterial Infection. Yonsei Med J. 2016;57:1139-1144
  16. Komatsuda A, Omokawa A, Fujiwara T, et al. Serum procalcitonin levels in patients with myeloperoxidase-antineutrophil cytoplasmic antibodi